Administration of alemtuzumab, a humanized antibody to target CD52, to a patient with diffuse cutaneous SSc resulted in sustained improvement in the skin. Tocilizumab, an anti-IL-6 receptor ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, and role of tocilizumab in rheumatoid arthritis (RA) are reviewed. Summary: Tocilizumab is a novel monoclonal antibody that ...